Company Overview
Pharmaffiliates has been awarded again with the most prestigious award of Top 100 Best Small & Medium Enterprises, third time in a row.
On 11th Dec. 2021, our Founder Director, Dr Ashok Kumar Sabharwal has been awarded the most prestigious award of “OUTSTANDING SCIENTIST AND INNOVATIVE ENTERPRENEUR” by Indian Institute of Material Management.
Transition from ISO Guide 34 (RC -1004) to ISO 17034 certification (RC -1004)
Awarded India SME 100 Awards on 28th June 2019 at International SME Convention 2019. This award is India’s most prestigious awards for small and medium Enterprises.
Pharmaffiliates proudly enters its 18th year since its inception in strongest ever position serving the leading pharmaceutical key opinion leaders across globe.
Certified with ISO Guide 34 (RC -1004)
Expanded our R&D facility to different locations. New R&D lab established in Hyderabad (Andhra Pradesh), India.
Audited and Accepted by USFDA .
Awarded India’s Best SMEs by Skoch group, a leading consultancy service group
Expanded the manufacturing successfully upto 22000 sq. ft.
Established 3 more R&D labs within the manufacturing facility.
Accredited with1SO 9001 and ISO 17025 (TC-7535)
Organization becomes an Indian MNC. Start operating from other global offices in USA, Canada, Europe and Turkey.
Officially registered and certified by Indian FDA.
Established R&D Centre in Panchkula (Haryana), India.
Officially registered and certified by ISO 9001:2008
Established with vision as a Research Based Organization by the founder Director Dr. A.K. Sabharwal.
